Tarsons Products Limited IPO
Tarsons Products Limited was a mainboard IPO in the Medical Equipment & Supplies sector, offered at ₹635–₹662 per share to raise ₹1,024 crore. The issue was subscribed 77.49× overall (QIBs 115.77×, NIIs 184.58×, retail 10.55×). It listed on 26 Nov 2021 at ₹682 and closed its first day at ₹818, a listing gain of +23.6% versus the ₹662 issue price. It now trades around ₹291 (-56.0% versus the issue price).
Frequently asked questions
- How many times was the Tarsons Products Limited IPO subscribed?
- The Tarsons Products Limited IPO was subscribed 77.49× overall — 115.77× in the QIB category, 184.58× among non-institutional investors, 10.55× in retail.
- What were the Tarsons Products Limited IPO listing gains?
- Tarsons Products Limited listed on 26 Nov 2021 at ₹682, closing its first day at ₹818 — a listing gain of +23.6% versus the ₹662 issue price.
- What were the retail allotment odds for the Tarsons Products Limited IPO?
- Retail was subscribed 10.55×, so a single-lot application had roughly a 9.5% chance of allotment (about 1 in 11), and allotment was finalised on 22 Nov 2021.
- What was the price band and lot size of the Tarsons Products Limited IPO?
- The price band was ₹635–₹662 per share, with a minimum lot of 22 shares (₹14,564 at the upper band).
- Who were the registrar and lead manager for the Tarsons Products Limited IPO?
- KFin Technologies Private Limited was the registrar, and ICICI Securities was the book-running lead manager.